49,259
edits
Difference between revisions of "NKX3.1"
Jump to navigation
Jump to search
no edit summary
| Line 8: | Line 8: | ||
*[[Invasive ductal carcinoma of the breast]] ~2% of cases.<ref name=pmid24996432>{{Cite journal | last1 = Asch-Kendrick | first1 = RJ. | last2 = Samols | first2 = MA. | last3 = Lilo | first3 = MT. | last4 = Subhawong | first4 = AP. | last5 = Sharma | first5 = R. | last6 = Illei | first6 = PB. | last7 = Argani | first7 = P. | last8 = Cimino-Mathews | first8 = A. | title = NKX3.1 is expressed in ER-positive and AR-positive primary breast carcinomas. | journal = J Clin Pathol | volume = 67 | issue = 9 | pages = 768-71 | month = Sep | year = 2014 | doi = 10.1136/jclinpath-2014-202272 | PMID = 24996432 }}</ref> | *[[Invasive ductal carcinoma of the breast]] ~2% of cases.<ref name=pmid24996432>{{Cite journal | last1 = Asch-Kendrick | first1 = RJ. | last2 = Samols | first2 = MA. | last3 = Lilo | first3 = MT. | last4 = Subhawong | first4 = AP. | last5 = Sharma | first5 = R. | last6 = Illei | first6 = PB. | last7 = Argani | first7 = P. | last8 = Cimino-Mathews | first8 = A. | title = NKX3.1 is expressed in ER-positive and AR-positive primary breast carcinomas. | journal = J Clin Pathol | volume = 67 | issue = 9 | pages = 768-71 | month = Sep | year = 2014 | doi = 10.1136/jclinpath-2014-202272 | PMID = 24996432 }}</ref> | ||
*[[Invasive lobular carcinoma]] ~10% of cases.<ref name=pmid24996432/> | *[[Invasive lobular carcinoma]] ~10% of cases.<ref name=pmid24996432/> | ||
*Urothelial carcinoma with glandular differentiation.<ref>{{Cite journal | last1 = Abdo | first1 = M | last2 = Hoyt | first2 = R | title = Weak NKX3.1 expression in a urothelial carcinoma: A diagnostic pitfall | journal = | volume = | issue = | pages = | month = | year = | doi = 10.1016/j.hpr.2022.300599 | PMID = | PMC = | url = https://www.sciencedirect.com/science/article/pii/S2772736X22000111 }}</ref> | |||
==See also== | ==See also== | ||